PL361663A1 - Termoformowalna kompozycja farmaceutyczna w postaci ciała stałego do kontrolowanego uwalniania perindoprilu - Google Patents

Termoformowalna kompozycja farmaceutyczna w postaci ciała stałego do kontrolowanego uwalniania perindoprilu

Info

Publication number
PL361663A1
PL361663A1 PL01361663A PL36166301A PL361663A1 PL 361663 A1 PL361663 A1 PL 361663A1 PL 01361663 A PL01361663 A PL 01361663A PL 36166301 A PL36166301 A PL 36166301A PL 361663 A1 PL361663 A1 PL 361663A1
Authority
PL
Poland
Prior art keywords
perindopril
pharmaceutical composition
controlled release
solid pharmaceutical
thermoformable
Prior art date
Application number
PL01361663A
Other languages
English (en)
Other versions
PL203836B1 (pl
Inventor
Patrick Wuthrich
Hervé Rolland
Gilles Briault
Gérald Pichon
François Tharrault
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL361663A1 publication Critical patent/PL361663A1/pl
Publication of PL203836B1 publication Critical patent/PL203836B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
PL361663A 2000-12-26 2001-12-21 Stała kompozycja farmaceutyczna o kontrolowanym uwalnianiu perindoprilu lub jego farmaceutycznie dopuszczalnej soli PL203836B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017013A FR2818550B1 (fr) 2000-12-26 2000-12-26 Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril
PCT/FR2001/004133 WO2002051407A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee de perindopril

Publications (2)

Publication Number Publication Date
PL361663A1 true PL361663A1 (pl) 2004-10-04
PL203836B1 PL203836B1 (pl) 2009-11-30

Family

ID=8858188

Family Applications (1)

Application Number Title Priority Date Filing Date
PL361663A PL203836B1 (pl) 2000-12-26 2001-12-21 Stała kompozycja farmaceutyczna o kontrolowanym uwalnianiu perindoprilu lub jego farmaceutycznie dopuszczalnej soli

Country Status (25)

Country Link
US (1) US20040115227A1 (pl)
EP (1) EP1345605B1 (pl)
JP (1) JP2004518666A (pl)
KR (1) KR100542473B1 (pl)
CN (1) CN1218696C (pl)
AR (1) AR031972A1 (pl)
AT (1) ATE299704T1 (pl)
AU (1) AU2002228118B2 (pl)
BR (1) BR0116536A (pl)
CA (1) CA2432896A1 (pl)
CZ (1) CZ297796B6 (pl)
DE (1) DE60112117T2 (pl)
DK (1) DK1345605T3 (pl)
EA (1) EA005139B1 (pl)
ES (1) ES2244672T3 (pl)
FR (1) FR2818550B1 (pl)
HU (1) HU230249B1 (pl)
MX (1) MXPA03005792A (pl)
NO (1) NO333590B1 (pl)
NZ (1) NZ526405A (pl)
PL (1) PL203836B1 (pl)
PT (1) PT1345605E (pl)
SK (1) SK286920B6 (pl)
WO (1) WO2002051407A1 (pl)
ZA (1) ZA200304405B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK50252005A3 (sk) * 2005-03-22 2006-10-05 Vúlm, A.S. Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
EA201490500A1 (ru) * 2011-08-30 2014-06-30 Университейт Гент Многослойный высвобождающий состав
RU2670447C2 (ru) * 2016-11-17 2018-10-23 Общество с ограниченной ответственностью "Изварино Фарма" Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002776A (en) * 1983-12-22 1991-03-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5589499A (en) * 1992-11-25 1996-12-31 Weth; Gosbert Dopaminergic agents for the treatment of cerebral and peripheral blood flow disorders
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19724696A1 (de) * 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee

Also Published As

Publication number Publication date
HUP0302524A2 (hu) 2003-12-29
CZ297796B6 (cs) 2007-03-28
ATE299704T1 (de) 2005-08-15
EA200300664A1 (ru) 2003-12-25
HU230249B1 (hu) 2015-11-30
EP1345605B1 (fr) 2005-07-20
DE60112117T2 (de) 2006-06-01
AR031972A1 (es) 2003-10-08
EA005139B1 (ru) 2004-12-30
MXPA03005792A (es) 2003-09-10
CN1218696C (zh) 2005-09-14
DK1345605T3 (da) 2005-10-10
HK1063739A1 (en) 2005-01-14
HUP0302524A3 (en) 2007-09-28
ES2244672T3 (es) 2005-12-16
PT1345605E (pt) 2005-11-30
NO20032738D0 (no) 2003-06-16
WO2002051407A1 (fr) 2002-07-04
NO333590B1 (no) 2013-07-15
ZA200304405B (en) 2004-06-25
SK9432003A3 (en) 2003-12-02
JP2004518666A (ja) 2004-06-24
KR100542473B1 (ko) 2006-01-11
CA2432896A1 (fr) 2002-07-04
EP1345605A1 (fr) 2003-09-24
FR2818550A1 (fr) 2002-06-28
CZ20032008A3 (cs) 2004-01-14
FR2818550B1 (fr) 2003-02-07
US20040115227A1 (en) 2004-06-17
DE60112117D1 (de) 2005-08-25
NZ526405A (en) 2004-12-24
PL203836B1 (pl) 2009-11-30
CN1482909A (zh) 2004-03-17
NO20032738L (no) 2003-06-16
BR0116536A (pt) 2003-10-21
SK286920B6 (sk) 2009-07-06
AU2002228118B2 (en) 2006-04-27
KR20030064877A (ko) 2003-08-02

Similar Documents

Publication Publication Date Title
AU2002229140A1 (en) Controlled release pharmaceutical composition
HUP0002469A3 (en) Solid thermoformable controlled-release pharmaceutical composition
HUP0300541A3 (en) Pharmaceutical compositions for sustained release, containing fluvastatin
GB0025208D0 (en) Delayed release pharmaceutical formulations
EP1383376A4 (en) PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
AU6089200A (en) Rapid immediate release oral dosage form
EP1424994A4 (en) PREPARATION OF A SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
HUP0301921A3 (en) Sustained release pharmaceutical compositions for paranteral administration of hydrophilic compounds
HUP0300373A3 (en) Sustained release vitamin composition and process for their preparation
HUP0103913A3 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
HUP0203108A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
EP1189597A4 (en) COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
HUP0302522A3 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
PT1121116E (pt) Composição farmacêutica de libertação sustentada de fluvastatina
AU2002228119A1 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
IL149427A0 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
AU2001232948A1 (en) Controlled release of drugs
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
AU2002351388A1 (en) Methods and compositions for controlled release of drugs
HUP0300928A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
HUP0204417A3 (en) Oral ciprofloxacin-composition of controlled release
HUP0302524A3 (en) Thermoformable solid pharmaceutical composition for controlled release of perindopril
EP1404301A4 (en) PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE, STABLE, CONTAINING PRAVASTATIN
AU2002228118A1 (en) Thermoformable solid pharmaceutical composition for controlled release of perindopril